Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Deloitte
Chinese Patent Office
Teva
Colorcon
Julphar
McKesson
Moodys
US Army

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,946,687

« Back to Dashboard

Summary for Patent: 4,946,687
Title: Dosage form for treating cardiovascular diseases
Abstract:An osmotic device is disclosed comprising a first composition, and a second composition with the beneficial drug isradipine in the first composition.
Inventor(s): Ayer; Atul D. (Palo Alto, CA), Swanson; David R. (Palo Alto, CA), Kuczynski; Anthony L. (Palo Alto, CA)
Assignee: Alza Corporation (Palo Alto, CA)
Application Number:07/267,894
Patent Claim Types:
see list of patent claims
Dosage form; Composition; Delivery; Device;

Drugs Protected by US Patent 4,946,687

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 4,946,687

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 402689 ➤ Try a Free Trial
Austria A242288 ➤ Try a Free Trial
Australia 2293888 ➤ Try a Free Trial
Australia 615215 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Daiichi Sankyo
Cipla
Express Scripts
Dow
Merck
Julphar
Mallinckrodt
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.